Fzata, Inc.

Halethorpe, United States

Fzata's novel platform modality for oral biologics is Bioengineered Probiotic Yeast Medicines (BioPYM) with over 10 GI drug candidates.

Sep 2024

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Fzata, Inc.'s investors?

Fzata, Inc.'s investors include National Institute of Neurological Disorders and Stroke.

Where is Fzata, Inc. headquartered?

Fzata, Inc. is headquartered in Halethorpe, United States.

What does Fzata, Inc. do?

Fzata's novel platform modality for oral biologics is Bioengineered Probiotic Yeast Medicines (BioPYM) with over 10 GI drug candidates.

What stage is Fzata, Inc. at?

Fzata, Inc. is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 24, 2024.

MLA

"Fzata, Inc. — Funding & Investors." VCBacked, September 24, 2024, https://www.vcbacked.co/company/fzata-inc. Accessed July 3, 2026.

APA

VCBacked. (2024). Fzata, Inc. — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/fzata-inc

Wikipedia (cite web)

{{cite web |title=Fzata, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/fzata-inc |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 24, 2024.